N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide

C49H61N5O6Si2 — CID 154415720

IUPACN-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide
SMILESCOc1cccc(C(c2ccccc2)(c2ccccc2)[C@@]2(n3cnc4c(NC(=O)c5ccccc5)ncnc43)O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)c1
InChIInChI=1S/C49H61N5O6Si2/c1-46(2,3)61(8,9)59-41-39(31-55)58-49(42(41)60-62(10,11)47(4,5)6,54-33-52-40-43(50-32-51-44(40)54)53-45(56)34-22-15-12-16-23-34)48(35-24-17-13-18-25-35,36-26-19-14-20-27-36)37-28-21-29-38(30-37)57-7/h12-30,32-33,39,41-42,55H,31H2,1-11H3,(H,50,51,53,56)/t39-,41-,42-,49+/m1/s1
InChIKeyGAESWGRXDGRBJY-IQBYBCMISA-N
MW872.23 g/mol
LogP9.95
Rot. Bonds13

About N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide

N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide (PubChem CID 154415720) has the molecular formula C49H61N5O6Si2 and a molecular weight of 872.23 g/mol. Its IUPAC name is N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide.

Molecular Properties

Compound NameN-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide
PubChem CID154415720
Molecular FormulaC49H61N5O6Si2
Molecular Weight872.23 g/mol
Exact Mass871.42
IUPAC NameN-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide
SMILESCOc1cccc(C(c2ccccc2)(c2ccccc2)[C@@]2(n3cnc4c(NC(=O)c5ccccc5)ncnc43)O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)c1
InChIInChI=1S/C49H61N5O6Si2/c1-46(2,3)61(8,9)59-41-39(31-55)58-49(42(41)60-62(10,11)47(4,5)6,54-33-52-40-43(50-32-51-44(40)54)53-45(56)34-22-15-12-16-23-34)48(35-24-17-13-18-25-35,36-26-19-14-20-27-36)37-28-21-29-38(30-37)57-7/h12-30,32-33,39,41-42,55H,31H2,1-11H3,(H,50,51,53,56)/t39-,41-,42-,49+/m1/s1
InChIKeyGAESWGRXDGRBJY-IQBYBCMISA-N
XLogP9.95
TPSA129.85 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds13
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500872.23
LogP ≤ 59.95
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triphenyl_methyl-silyl', 'substructure': 'N/A'}

Analyze N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide?
The IUPAC name of N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide (CID 154415720) is N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide.
What is the SMILES notation for N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide?
The canonical SMILES for N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide is COc1cccc(C(c2ccccc2)(c2ccccc2)[C@@]2(n3cnc4c(NC(=O)c5ccccc5)ncnc43)O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)c1.
What is the InChIKey of N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide?
The InChIKey is GAESWGRXDGRBJY-IQBYBCMISA-N. The full InChI is InChI=1S/C49H61N5O6Si2/c1-46(2,3)61(8,9)59-41-39(31-55)58-49(42(41)60-62(10,11)47(4,5)6,54-33-52-40-43(50-32-51-44(40)54)53-45(56)34-22-15-12-16-23-34)48(35-24-17-13-18-25-35,36-26-19-14-20-27-36)37-28-21-29-38(30-37)57-7/h12-30,32-33,39,41-42,55H,31H2,1-11H3,(H,50,51,53,56)/t39-,41-,42-,49+/m1/s1.
What are the key properties of N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide?
N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide has a molecular weight of 872.23 g/mol, XLogP of 9.95, 13 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[9-[(2R,3R,4R,5R)-3,4-bis[[tert-butyl(dimethyl)silyl]oxy]-5-(hydroxymethyl)-2-[(3-methoxyphenyl)-diphenylmethyl]oxolan-2-yl]purin-6-yl]benzamide is sourced from PubChem (CID 154415720), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).